Quest Diagnostics Incorporated (DGX)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 126.98 |
| Open | 127.25 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's range | 125.42 - 127.33 |
| 52-week range | 119.59 - 148.62 |
| Volume | |
| Avg. volume | 1,034,317 |
| Market cap | 13.983B |
| Beta (5Y monthly) | 0.89 |
| PE ratio (TTM) | 16.81 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.00 (2.38%) |
| Ex-dividend date | 05 Apr 2024 |
| 1y target est | N/A |
- Zacks
Earnings Preview: Quest Diagnostics (DGX) Q1 Earnings Expected to Decline
Quest Diagnostics (DGX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Quest Diagnostics (DGX) to Post Q1 Earnings: What's in Store?
Acquisitions and partnerships with health plans are expected to drive Quest Diagnostics' (DGX) base business performance in the first quarter of 2024.
- Zacks
Myriad Genetics (MYGN) Announces Favorable Research Results
Myriad Genetics' (MYGN) latest positive initial study outcome is likely to improve clinical outcomes and reduce overall healthcare costs.
© 2024 Yahoo. All rights reserved.